Inflammation-Independent Antinociceptive Effects of DF2755A, a CXCR1/2 Selective Inhibitor: A New Potential Therapeutic Treatment for Peripheral Neuropathy Associated to Non-Ulcerative Interstitial Cystitis/Bladder Pain Syndrome
Laura Brandolini(Dompé (Italy)), Marcello Allegretti(Dompé (Italy))
Cited by 7
Related Papers
Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: Prevention of reperfusion injury
|Proceedings of the National Academy of Sciences|2004|339
2-Arylpropionic CXC Chemokine Receptor 1 (CXCR1) Ligands as Novel Noncompetitive CXCL8 Inhibitors
|Journal of Medicinal Chemistry|2005|127
Design of Noncompetitive Interleukin-8 Inhibitors Acting on CXCR1 and CXCR2
|Journal of Medicinal Chemistry|2007|97
Targeting the minor pocket of C5aR for the rational design of an oral allosteric inhibitor for inflammatory and neuropathic pain relief
|Proceedings of the National Academy of Sciences|2014|78
Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non‐competitive allosteric inhibitor
|British Journal of Pharmacology|2011|74